otitis%20media%20-%20acute
OTITIS MEDIA - ACUTE
Otitis media is a general term used to describe inflammation of the middle ear which may be caused by an acute infection.
The symptoms are usually nonspecific and include otalgia (pulling of ear in an infant), irritability, otorrhea with or without fever.
Symptoms of upper respiratory tract infection may also be present.

Differential Diagnosis

Otitis Externa

  • May cause ear ache similar to acute otitis media (AOM) but has a normal-appearing eardrum

Foreign Body

  • May cause pain & should be suspected particularly in children

Otitis Media w/ Effusion (OME)

  • Typically diagnosed if there is middle ear effusion (MEE) on pneumatic otoscopy w/o signs of acute inflammation
  • Otoscopy may show retracted tympanic membrane w/ color change; bulging eardrum is usually absent
  • Main symptom is hearing loss

Myringitis

  • Inflammation of the tympanic membrane usually associated w/ viral upper respiratory tract infection (URTI)

Chronic Suppurative Otitis Media

  • Persistent inflammation associated w/ perforated tympanic membrane & drainage of exudate for >6 weeks
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Dr. Joseph Delano Fule Robles, 12 Feb 2019

A team of investigators from the University of Hong Kong (HKU) identified high-risk Epstein Barr virus (EBV) variants present in 97 percent of nasopharyngeal carcinoma (NPC) cases.

5 days ago
New drug applications approved by US FDA as of 01- 15 February 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Pearl Toh, 23 Aug 2018
Restoration of CD4/CD8 ratio on combination antiretroviral therapy (cART) was associated with decreased risk of Kaposi sarcoma (KS) while baseline CD8 count was related to non-Hogkin lymphoma (NHL) risk in people living with HIV (PLHIV) who had achieved viral suppression on cART, according to the COHERE* study presented at the AIDS International Conference (AIC) 2018.
Roshini Claire Anthony, 16 Jan 2019

A once-daily oral dose of sofosbuvir and velpatasvir for 12 weeks leads to sustained virological response (SVR) in a majority of patients with chronic hepatitis C virus (HCV) infection, according to an Asian study. However, the efficacy of this regimen may be reduced in patients with HCV genotype 3b with cirrhosis.